title: Comparison study of two commercially available methods for the determination of golimumab and anti-golimumab antibody levels in patients with rheumatic diseases.
authors.forename: Sergio
authors.initials: S
authors.lastname: Martín
authors.forename: Ainhoa Ruiz
authors.initials: AR
authors.lastname: del Agua
authors.forename: Nerea
authors.initials: N
authors.lastname: Torres
authors.forename: Dora
authors.initials: D
authors.lastname: Pascual-Salcedo
authors.forename: Chamaida
authors.initials: C
authors.lastname: Plasencia
authors.forename: Begoña
authors.initials: B
authors.lastname: Ruiz-Argüello
authors.forename: Antonio
authors.initials: A
authors.lastname: Martínez
authors.forename: Rosaura
authors.initials: R
authors.lastname: Navarro
authors.forename: Daniel
authors.initials: D
authors.lastname: Nagore
mesh_terms: D000911:Antibodies, Monoclonal / Q000097:blood* / Q000276:immunology; D004797:Enzyme-Linked Immunosorbent Assay / Q000592:standards*; D006801:Humans; D011863:Radioimmunoassay / Q000592:standards*; D012216:Rheumatic Diseases / Q000097:blood* / Q000276:immunology*
chemical_list: D000911:Antibodies, Monoclonal; C529000:golimumab